MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
11.07
+0.04 (0.36%)
Nov 20, 2026, 4:00 PM EST - Market closed
MoonLake Immunotherapeutics Employees
MoonLake Immunotherapeutics had 130 employees as of December 31, 2025. The number of employees increased by 30 or 30.00% compared to the previous year. That makes MoonLake Immunotherapeutics the 29,844th largest employer in the world and 3,771st in the United States.
Employees
130
Change (1Y)
30
Growth (1Y)
30.00%
Revenue / Employee
n/a
Profits / Employee
-$2,103,723
Market Cap
942.13M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 130 | 30 | 30.00% |
| Dec 31, 2024 | 100 | 50 | 100.00% |
| Dec 31, 2023 | 50 | 30 | 150.00% |
| Dec 31, 2022 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 721 |
| Pharming Group | 407 |
| Omeros | 175 |
| Verastem | 102 |
| Odyssey Therapeutics | 100 |
| SpyGlass Pharma | 88 |
| Seaport Therapeutics | 59 |
| Jade Biosciences | 55 |
MLTX News
- 15 days ago - MoonLake Immunotherapeutics initiated with a Buy at Chardan - TheFly
- 17 days ago - MoonLake Immunotherapeutics reports Q3 EPS (93c), consensus (78c) - TheFly
- 17 days ago - MoonLake Reports Third Quarter 2026 Financial Results and Provides a Business Update - GlobeNewsWire
- 17 days ago - MoonLake Immunotherapeutics Quarterly report: Q3 2026 - Filings
- 17 days ago - MoonLake Immunotherapeutics Earnings release: Q3 2026 - Filings
- 3 months ago - MoonLake price target raised to $50 from $45 at H.C. Wainwright - TheFly
- 3 months ago - MoonLake's psoriatic arthritis drug meets key goals in late-stage trial - Reuters
- 3 months ago - MoonLake Immunotherapeutics reports Q2 EPS (84c), consensus (90c) - TheFly